Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

27 mars 2026 06h31 HE | Source: Johnson & Johnson EMEA

Johnson & Johnson’s DARZALEX® (daratumumab) becomes the first oncology injectable approved for administration by patients or caregivers

Landmark decision by CHMP grants approval for self or caregiver administration for patients living with multiple myeloma1 Milestone is a testament to ten years of daratumumab experience and...
15 mai 2025 09h43 HE | Source: Research and Markets

Daratumumab or Darzalex Market Research Report 2025: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2019-2024, 2024-2029F, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Daratumumab or Darzalex Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
30 avr. 2025 04h49 HE | Source: Research and Markets

Darzalex Faspro Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Darzalex Faspro Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...